2-134718796-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate
The ENST00000281924.6(TMEM163):c.140A>T(p.Glu47Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000349 in 1,146,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000281924.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM163 | NM_030923.5 | c.140A>T | p.Glu47Val | missense_variant | 1/8 | ENST00000281924.6 | NP_112185.1 | |
LOC105373629 | XR_923354.4 | n.456+229T>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM163 | ENST00000281924.6 | c.140A>T | p.Glu47Val | missense_variant | 1/8 | 1 | NM_030923.5 | ENSP00000281924 | P1 | |
ENST00000655237.1 | n.380+229T>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 150018Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000201 AC: 2AN: 995888Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 468658
GnomAD4 genome AF: 0.0000133 AC: 2AN: 150124Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73320
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.140A>T (p.E47V) alteration is located in exon 1 (coding exon 1) of the TMEM163 gene. This alteration results from a A to T substitution at nucleotide position 140, causing the glutamic acid (E) at amino acid position 47 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at